Active substance roxadustat
Holder Astellas Pharma B.V.
Status Running
Indication treatment of symptomatic anaemia of Chronic Kidney Disease in non-dialysis and dialysis patients, and where use of available treatment (IV iron or injectable ESAs) is not appropriate or is expected not to be appropriate, or patients who have a known contraindication for the currently available treatment or who do not tolerate the currently available treatment, or are expected not to tolerate this product
Public documents Approbation
  Information for the patient
  Informed Consent
Laast update 08/08/2022


Last updated on 16/09/2022